AILERON THERAPEUTICS INC's ticker is ALRN and the CUSIP is 00887A105. A total of 30 filers reported holding AILERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 3,799 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -99.0% | 3,799 | -98.0% | 0.00% | – |
| Q1 2022 | $100,000 | -12.3% | 194,200 | -4.6% | 0.00% | – |
| Q4 2021 | $114,000 | -42.4% | 203,488 | +4.6% | 0.00% | – |
| Q3 2021 | $198,000 | -20.5% | 194,529 | -2.1% | 0.00% | – |
| Q2 2021 | $249,000 | +1560.0% | 198,657 | +327.8% | 0.00% | – |
| Q1 2020 | $15,000 | -55.9% | 46,437 | -21.3% | 0.00% | – |
| Q4 2019 | $34,000 | -15.0% | 59,009 | -1.0% | 0.00% | – |
| Q3 2019 | $40,000 | +11.1% | 59,635 | +20.5% | 0.00% | – |
| Q2 2019 | $36,000 | +2.9% | 49,485 | +179.6% | 0.00% | – |
| Q1 2019 | $35,000 | +118.8% | 17,698 | -5.7% | 0.00% | – |
| Q4 2018 | $16,000 | -66.0% | 18,776 | +9.9% | 0.00% | – |
| Q3 2018 | $47,000 | -46.6% | 17,078 | +4.2% | 0.00% | – |
| Q2 2018 | $88,000 | -95.4% | 16,385 | -93.1% | 0.00% | – |
| Q1 2018 | $1,918,000 | -23.4% | 235,957 | -0.7% | 0.00% | – |
| Q4 2017 | $2,504,000 | -20.9% | 237,512 | +0.5% | 0.00% | – |
| Q3 2017 | $3,164,000 | – | 236,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 16,609,449 | $4,318,000 | 8.01% |
| KCK LTD. | 646,817 | $168,000 | 0.24% |
| Ikarian Capital, LLC | 2,892,316 | $752,000 | 0.14% |
| BVF INC/IL | 5,265,555 | $1,369,000 | 0.07% |
| Urban Wealth Management, LLC | 37,314 | $10,000 | 0.03% |
| Game Plan Financial Advisors, LLC | 103,000 | $27,000 | 0.02% |
| RIDGECREST WEALTH PARTNERS, LLC | 10,000 | $3,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 278,743 | $72,000 | 0.00% |
| Taconic Capital Advisors LP | 135,000 | $35,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 75,078 | $20,000 | 0.00% |